SPARC
SUN PHARMA ADV.RES.CO.LTD

133.74 +0.92 (+0.69%)

Don't consider investing in SPARC now, it is risky at the moment

26 Nov, 20255 min read

SPARC ranked worse than it's peers today. On a longer term basis, investors in SUN PHARMA ADV.RES.CO.LTD made +0.04% per day. Wednesday's performance of +0.69% was a significant outperformance compared to it's daily average.

Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}}